American Lung Association Commends Passage of Bipartisan Health Funding

Today, the House passed, and President Trump signed into law, critical funding for the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), ensuring continued investment in lifesaving public health and research programs. In response, American Lung Association President and CEO Harold Wimmer issued the following statement:

"The American Lung Association welcomes the passage of funding for federal health programs, which maintains CDC funding and includes a $400 million increase for NIH. These investments support proven efforts to prevent and manage asthma, reduce tobacco use, advance lung cancer prevention and drive lifesaving research across the full spectrum of lung disease. This reflects bipartisan recognition that sustained investment in public health and research saves lives and strengthens communities.”
“Following a year of devastating cuts to public health programs and infrastructure, as well as disruptions to clinical trials and research, this funding is more important than ever. These investments will help people manage chronic lung diseases like asthma, prevent kids from starting to use tobacco, reduce avoidable emergency room visits and hospitalizations, and keep research moving toward greater treatments and cures.

“Congress has made its intent clear. We now call on the Department of Health and Human Services to fully implement the law and ensure that CDC and NIH programs receive the funding Congress provided. The American Lung Association will continue working to ensure that these investments deliver on their promise to protect and improve lung health.”